The liver concentrations of interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α), the two key inflammatory markers associated with NAFLD, were also reduced (Fig. 1E, F). This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.